News

The acquisition brings two products to Retrophin that have been approved by the US Food and Drug Administration (FDA). Chenodal (chenodeoxycholic acid — a synthetic bile acid also

AllStar president Dr. Bagi noted that the company is extremely pleased to be able to work with BIOVEA, as they are an established successful online sales organization, and

Discovered by Takeda, TAK-438 belongs to a new class of acid secretion inhibitors called potassium-competitive acid blockers (P-CAB). In February 2014, a new drug application (NDA) for TAK-438

The deal leverages Xenon’s Extreme Genetics discovery platform to focus on rare phenotypes where individuals have an inability to perceive pain or where individuals have non-precipitated spontaneous severe

In 2013, Golden State Foods (GSF), a diversified food processors and distributors in the US, acquired a controlling interest in KanPak, a supplier of beverages and desserts using

MST-188 has already secured FDA orphan drug designation for the treatment of ALI, an acute complication of peripheral arterial disease that describes a sudden decrease in perfusion of

The new solution is aimed at helping providers and communities reduce hospital readmissions and re-incarcerations as well as help create more comprehensive patient health records. As of now,

NeoStem Grants and Academic Liaison director Dr Denis O. Rodgerson and Dr Vincent Falanga, The Barbara A. Gilchrest Professor of Dermatology and Professor of Biochemistry at the Boston

Proceeds from the financing will be used to further develop its first two pharmaceutical products and its associated drug delivery technology. The first product is a novel drug-device